» Articles » PMID: 37910197

The Many Faces of the Megakaryocytes and Their Biological Implications

Overview
Specialty Hematology
Date 2023 Nov 1
PMID 37910197
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Single-cell RNA sequencing studies have revealed transcriptional heterogeneity within the megakaryocytic lineage and the identified unique subsets. In this review, we discuss the functional and phenotypic plasticity of these subpopulations as well as the impacts on health and disease.

Recent Findings: Megakaryocytes (MKs) can be transcriptionally categorized into platelet generating, niche supporting, immune, and cycling cells, which are distinguished by their unique gene expression patterns and cellular markers. Additionally, a significant population of these cells has been established to reside in the nonhematopoietic tissues and they display enhanced immune-related characteristics. Combined with the location in which the megakaryocytes exist, these cells can play unique roles dictated by their current environment and biological needs, including responding to changes in pathogen exposure.

Summary: Advances in megakaryocyte research has elucidated the existence of multiple subpopulations of MKs that serve different functions. These subpopulations implicate a greater potential for MKs to be regulators of health and suggest new avenues for treatments and therapies in related diseases.

Citing Articles

A modern overview of the process of platelet formation (thrombocytopoiesis) and its dependence on several factors.

Ivanovna Gabrilchak A, Anatolievna Gusyakova O, Aleksandrovich Antipov V, Alekseevna Medvedeva E, Leonidovna Tukshumskaya L Biochem Med (Zagreb). 2024; 34(3):030503.

PMID: 39435166 PMC: 11493462. DOI: 10.11613/BM.2024.030503.

References
1.
Beaulieu L, Lin E, Morin K, Tanriverdi K, Freedman J . Regulatory effects of TLR2 on megakaryocytic cell function. Blood. 2011; 117(22):5963-74. PMC: 3112041. DOI: 10.1182/blood-2010-09-304949. View

2.
Yeung A, Villacorta-Martin C, Hon S, Rock J, Murphy G . Lung megakaryocytes display distinct transcriptional and phenotypic properties. Blood Adv. 2020; 4(24):6204-6217. PMC: 7757004. DOI: 10.1182/bloodadvances.2020002843. View

3.
Bruns I, Lucas D, Pinho S, Ahmed J, Lambert M, Kunisaki Y . Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat Med. 2014; 20(11):1315-20. PMC: 4258871. DOI: 10.1038/nm.3707. View

4.
Nakamura-Ishizu A, Takubo K, Fujioka M, Suda T . Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin. Biochem Biophys Res Commun. 2014; 454(2):353-7. DOI: 10.1016/j.bbrc.2014.10.095. View

5.
Finkielsztein A, Schlinker A, Zhang L, Miller W, Datta S . Human megakaryocyte progenitors derived from hematopoietic stem cells of normal individuals are MHC class II-expressing professional APC that enhance Th17 and Th1/Th17 responses. Immunol Lett. 2014; 163(1):84-95. PMC: 4278953. DOI: 10.1016/j.imlet.2014.11.013. View